in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Merck Extends Enzymes Collaboration with Codexis
2:37 PM MDT | May 22, 2012 | Rebecca Coons
Codexis (Redwood City), an enzymes technology firm, says Merck has signed a three-year extension to an ongoing catalyst and process development collaboration for pharmaceutical manufacturing. Under the terms of the deal, Merck will continue to use Codexis’ enzyme products to develop cost- and resource-efficient manufacturing processes for therapeutic candidates. The initial agreement was signed in April 2007, and has been extended to 2015. To date, Merck has used Codexis’ enzymes “extensively across programs in various stages of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee